Abraxane and Tarceva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abraxane (paclitaxel) and Tarceva (erlotinib hydrochloride). Common drug interactions include death among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Abraxane and Tarceva. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

On Jul, 11, 2026

36 people who take Abraxane and Tarceva together, and have interactions are studied.

What are the common drug interactions of Abraxane and Tarceva, by gender? *:

female:

Death
Disease progression
Cough
Dyspnoea (difficult or laboured respiration)
Lung neoplasm malignant (cancer tumour of lung)
Metastases to liver (cancer spreads to liver)
Metastases to lung (cancer spreads to lung)
Neoplasm (tumour)
Pleural effusion (water on the lungs)
Pleurodesis

male:

Nausea (feeling of having an urge to vomit)
Death
Platelet count decreased
Adrenal disorder
Adverse drug reaction
Anastomotic ulcer
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacteraemia (presence of bacteria in the blood)
Chronic kidney disease

What are the common drug interactions of Abraxane and Tarceva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombosis (formation of a blood clot inside a blood vessel)
Death
Venous thrombosis limb (blood clot that forms in a vein in the limb)

60+:

Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Adverse drug reaction
Anastomotic ulcer
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacteraemia (presence of bacteria in the blood)
Chronic kidney disease
Confusional state
Constipation

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 19.44%
Breast Cancer Female: 6 people, 16.67%
Pancreatic Carcinoma (pancreatic cancer): 4 people, 11.11%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 11.11%
Non-Small Cell Lung Cancer Stage Iv: 3 people, 8.33%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 5.56%
Neoplasm Malignant (cancer tumour): 2 people, 5.56%
Metastases To Liver (cancer spreads to liver): 2 people, 5.56%
Metastases To Bone (cancer spreads to bone): 2 people, 5.56%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and Tarceva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously